Publications
Original Article
Therapeutic and Prophylactic Antitumor Activity of an Oral Inhibitor of Fucosylation in Spontaneous Mammary Cancers
Tumor Microenvironment
2020
Authors:
Disis ML, Corulli LR, Gad EA, Koehnlein MR, Cecil DL, Senter PD, Gardai SJ, Okeley NM.
Journal:
Molecular Cancer theraputics
Volume:
19(5)
Page:
1102-1109
Pubmed:
Original Article
Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical Trial
Tumor Microenvironment
2017
Authors:
Salazar, LG, Lu, H, Reichow, JL, Childs, JS, Coveler, AL, Higgins, DM, Waisman, J, Allison, KH, Dang, Y, and Disis, ML
Journal:
JAMA Oncology
Volume:
3(7)
Page:
969-973
Pubmed:
Original Article
Gene expression markers of Tumor Infiltrating Leukocytes
Tumor Microenvironment
2017
Authors:
Danaher P, Warren S, Dennis L, D'Amico L, White A, Disis ML, Geller MA, Odunsi K, Beechem J, Fling SP.
Journal:
Journal of Immunotherapy Cancer
Volume:
5
Page:
18
Pubmed:
Original Article
Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity
Tumor Microenvironment
2016
Authors:
Dietsch GN, Lu H, Yang Y, Morishima C, Chow LQ, Disis ML, Hershberg RM.
Journal:
PLoS One
Volume:
11(2)
Page:
e0148764
Pubmed:
Original Article
Protein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation
Tumor Microenvironment
2014
Authors:
Yang Y, Inatsuka C, Gad E, Disis ML, Standish LJ, Pugh N, Pasco DS, Lu H
Journal:
Innate Immunity / Sage Journals
Volume:
20(8)
Page:
857-66
Pubmed:
Original Article
Protein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation
Tumor Microenvironment
2013
Authors:
Yang, Y., Inatsuka, C., Gad, E., Disis, M.L., Standish, L.J., Pugh, N., Pasco, D.S. and Lu, H
Journal:
Innate Immunity / Sage Journals
Volume:
20(8)
Page:
857-66
Pubmed:
Original Article
Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK
Tumor Microenvironment
2013
Authors:
Inatsuka C, Yang Y, Gad E, Rastetter L, Disis ML, Lu H.
Journal:
Cancer Immunology Immunotherapy
Volume:
62(8)
Page:
1335-45
Pubmed:
Original Article
Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant
Tumor Microenvironment
2013
Authors:
Engel AL, Sun GC, Gad E, Rastetter LR, Strobe K, Yang Y, Dang Y, Disis ML, Lu H
Journal:
immunobiology
Volume:
218(12)
Page:
1468-76
Pubmed:
Original Article
VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC
Tumor Microenvironment
2012
Authors:
Lu H., Dietsch G. N., Matthews M. A., Yang Y., Ghanekar S., Inokuma M., Suni M., Maino V. C., Henderson K. E., Howbert J. J., Disis M. L., Hershberg R. M.
Journal:
Clinical Cancer Research
Volume:
18(2)
Page:
499-509
Pubmed:
Original Article
Dendritic cell-activating vaccine adjuvants differ in the ability to elicit antitumor immunity due to an adjuvant-specific induction of immunosuppressive cells
Tumor Microenvironment
2012
Authors:
Dang Y, Wagner WM, Gad E, Rastetter L, Berger CM, Holt GE, Disis ML.
Journal:
Clinical Cancer Research
Volume:
18(11)
Page:
3122-31
Pubmed: